Graduated from the University of Puget Sound, Washington with a Bachelor of Science degree in Biology/Chemistry in 1979 after which he received his Medical Technology diploma from Cleveland Clinic, Ohio in 1981. Columbia University, New York, USA, was his graduate school where he achieved his MA in Pathology (1982), continued his MPhil in Pathology (1984) and gained his PhD in Pathobiology (Tumor Immunology) in 1987.
In the last quarter of 2018 he was appointment Executive Director, Research Affairs (Corporate) at King Faisal Specialist Hospital & Research Centre (KFSH&RC). In addition to this responsibility, he is also an Adjunct Professor in the College of Medicine at Alfaisal University, Riyadh and an Advisor at King Abdulaziz City for Science and Technology. He previously holds the position of Executive Director, Research Centre at KFSH&RC from 1996 until the 3rd quarter of 2018.
Through his work as Executive Director of Research Centre at KFSH&RC and at King Salman Center for Disability Research, he gained extensive experience in various national research and studies and established national and international partnerships that had a significant impact and remarkable output.
For over 25 years he worked in the field of research management and served as the transformation engineer of Research Centre, with an aim of transforming the institution to a distinguished national center in the field of medical clinical research. He was also a pioneer in the establishing technical companies to transform research production into concrete services.
His research interest is in Tumor and Transplantation Immunology where he has published more than 150 full-length papers and meeting abstracts.
He is a member of many professional societies and he holds membership in a number of high level committees locally which include Board of Directors, King Abdulaziz City for Science and Technology (KACST), Board of Trustees, King Salman Center for Disability Research, Oversight Committee for the National Strategy for Science and Technology and Innovation, College of Medicine Board of AlFaisal University, Technology Advisory Council of Saudi Technology Development and Investment Company (TAQNIA); and internationally including the Board of Trustees and Scientific Advisory Council of Dubai Harvard Foundation for Medical Research, Governing Council of International Network for Cancer Treatment and Research (INCTR), Executive and Scientific Committees of International Cancer Genome Consortium (ICGC), Advisory Board, KACST-UCSD Joint Center for Excellence in Nanomedicine and Engineering, Executive Committee of International Rare Diseases Research Consortium (IRDiRC), Technology Advisory Council of Saudi Technology Development and Investment Company (TAQNIA) Board of Directors International.